In this article, we will take a look at the 15 best large-cap value stocks to buy in 2025.

Why is this Portfolio Manager Cautiously Optimistic?

The market outlook is as uncertain as it gets. On January 18, Robert Pavlik, senior portfolio manager at Dakota Wealth Management, appeared in an interview on Wealth at Yahoo Finance to share his market outlook, which happens to be rather optimistic or “cautiously optimistic.”

Pavlik shared that as the new administration takes over he is optimistic about how the market will play out in the near future. He added that the new government is expected to do some deregulation and cut corporate taxes, which are supposedly going to boost earnings despite inflation being a concern. He also explained why he was cautious earlier. He stated that the easing cycle was more uncertain and the new government was emphasizing tariffs earlier, however, as time has passed, Pavlik has grown to become more optimistic about the market.

He also expects the economy to grow, suggesting that the US is nowhere near a recession. In addition to that, Pavlik is confident that valuations are expected to ease, tariffs seem to be a “bargaining chip,” and mass deportations are “not going to happen.” In addition to that, he believes new energy policies to lower the price of oil and gas, resulting in lower costs incurred by firms across nearly every industry.

By the middle of 2025, Pavlik expects the Fed to be back issuing multiple rate cuts. Overall, he expects 2025 to be a solid year for equities, with expectations of the S&P 500 reaching 6,750, representing a 13-14% growth from January 18, 2025. While he agrees that in the near term, especially in the first 100 days of the new government, there are reasons to be slightly cautious, he remains confident that the new policies will work out as the market goes forward.

Speaking of inflation, Pavlik reiterated that the new energy policies will definitely push oil companies to produce more oil as a result of cost reductions. These cost reductions are expected to have a multiplier effect on grocery companies which will ultimately cater to inflationary pressures, added the portfolio manager. This coupled with his expectation of the Fed returning to its planned easing cycle will likely fuel shared investor sentiment and consumer confidence.

While the first 100 days of the new administration may be uncertain and volatile, there are some stocks known to have been stable through rough or smooth market conditions. That said, let’s take a look at the 15 best large-cap value stocks to buy in 2025.

Our Methodology

We used Finviz to look for companies operating in value sectors such as consumer defensive, financials, healthcare, and utilities. We only focused on companies with a market cap of more than $10 billion. We then examined the analyst upside surrounding 25 stocks and picked the 15 stocks with the highest upside as of January 20, 2025. We have also included the hedge fund sentiment around each stock.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).

15 Best Large-Cap Value Stocks to Buy in 2025

15. HDFC Bank Limited (NYSE:HDB)

Analyst Upside as of January 20, 2025: 20%

Number of Hedge Fund Holders: 41

HDFC Bank Limited (NYSE:HDB) is a financial services company based in India, ranking 15th on our list of the best large-cap value stocks to buy in 2025. The company offers personal banking and online net banking services. As of September 30, 2024, the HDFC has more than 9,000 branches and nearly 21,000 ATMs across 4,088 cities and towns across the country.

The company’s expansion across India is remarkable. On December 31, 2024, HDFC Bank Limited (NYSE:HDB) announced that it will now offer 40 products and services in Rajasthan digitally using its e-Mitra platform, an incredible feat for its transition to become a fully digital organization. Similarly, towards the end of November 2024, the company launched a new and improved savings program for rural India, paving the way for socioeconomic development in the country.

In the fiscal second quarter of 2024, the company grew its revenue by 9.2% and net interest income by 10%, explaining why analysts are bullish on the stock and their median price target implies an upside of 20% from current levels.

14. AbbVie Inc. (NYSE:ABBV)

Analyst Upside as of January 20, 2025: 20%

Number of Hedge Fund Holders: 68

AbbVie Inc. (NYSE:ABBV) is a pharmaceutical company with an immense focus on advanced research. ABBV is making strides in drug development and treatment discovery. In the third quarter of 2024, the company generated $14.46 billion in worldwide net revenues, an increase of nearly 4%. Global net revenues for its immunology portfolio were $7.05 billion, up by nearly 4%. The company also saw significant revenue growth rates in its oncology and neuroscience portfolio, up by 12% and 16% respectively.

As part of its growing portfolio and expansion plans, on January 13, AbbVie Inc. (NYSE:ABBV) announced a partnership with Simcere Zaiming to develop a new antibody candidate, SIM0500. As of now, the candidate is in phase 1 of clinical trials in patients with multiple myeloma in China and the United States. Earlier in December 2024, the company announced an agreement to acquire Nimble Therapeutics to strengthen its immunology portfolio.

Over the past few months, AbbVie Inc. (NYSE:ABBV) received approvals for major drugs and secured crucial strategic deals, positioning it as a leader in the pharmaceutical industry. At the end of Q3 2024, 68 hedge funds were bullish on the stock.